综合干预措施下评估首次<sup>131</sup>I清甲治疗对分化型甲状腺癌患者唾液腺的慢性损伤

孔维静; 徐颖; 孔维静; 徐颖

doi:10.3760/cma.j.issn.1673-4114.2018.01.006

[1]

宋润波, 孟增智, 贾清雨.分化型甲状腺癌的治疗新进展[J].现代中西医结合杂志, 2015, 24(24):2728-2730. DOI:10.3969/j.issn.1008-8849.2015.24.043.
Song RB, Meng ZZ, Jia QY. New progress in the treatment of differentiated thyroid carcinoma[J]. Modern J Integr Tradit Chin West Med, 2015, 24(24):2728-2730. doi: 10.3969/j.issn.1008-8849.2015.24.043

[2]

Maruoka Y, Baba S, Isoda T, et al. A Functional Scoring System Based on Salivary Gland Scintigraphy for Evaluating Salivary Gland Dysfunction Secondary to ¹³¹I therapy in Patients with Differentiated Thyroid Carcinoma[J]. J Clin Diagn Res, 2017, 11(8):TC23-TC28. DOI:10.7860/JCDR/2017/27340.10431.

[3]

Jonklaas J, Wang H, Esposito G. Salivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy[J/OL]. Front Endocrinol (Lausanne), 2015, 6: 100[2017-11-07]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470264/. DOI: 10.3389/fendo.2015.00100.

[4]

赵宁宁, 孙建梅, 李凤岐.唾液腺显像检测131碘治疗对分化型甲状腺癌患者唾液腺功能的影响[J].潍坊医学院学报, 2015, 37(6):405-408. DOI:10.3969/j.issn.1004-3101.2015.06.002.
Zhao NN, Sun JM, Li FQ. Influence of radioiodine treatment on the salivary glands evaluated by ⁹⁹Tc^mO₄^- salivary glands dynamic imaging for the postoperative patients with DTC[J]. Acta Acad Med Weifang, 2015, 37(6):405-408. doi: 10.3969/j.issn.1004-3101.2015.06.002

[5]

姚红霞, 张金山, 袁文金.唾液腺动态显像对口干患者唾液腺功能受损的诊断评价[J].影像诊断与介入放射学, 2014, 23(5):383-387. DOI:10.3969/j.issn.1005-8001.2014.05.005.
Yao HX, Zhang JS, Yuan WJ. Scintigraphic evaluation of salivary gland function in patients with xerostomia[J]. Diagn Imaging Interventional Radiol, 2014, 23(5):383-387. doi: 10.3969/j.issn.1005-8001.2014.05.005

[6]

朱玉泉, 段东, 庞华, 等.分化型甲状腺癌患者首次大剂量¹³¹I治疗后不同时间开始酸刺激对减少急性唾液腺损伤的研究[J].重庆医学, 2014, 43(22):2890-2892. DOI:10.3969/j.issn.1671-8348.2014.22.022.
Zhu YQ, Duan D, Pang H, et al. Different beginning time of acid stimulation to reduce the acute damage of salivary glands after high-dose iodine-131 therapy for the post-surgery DTC patients[J]. Chongqing Med, 2014, 43(22):2890-2892. doi: 10.3969/j.issn.1671-8348.2014.22.022

[7]

Van Nostrand D. Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer[J]. Oral Dis, 2011, 17(2):154-161. DOI:10.1111/j.1601-0825.2010.01726.x.

[8]

李伟, 汤日杰, 彭俊琴, 等. ROI和ADC值标准差在预测鼻咽癌近期疗效中的相关分析[J].中国临床医学影像杂志, 2017, 28(2):85-88. DOI:10.3969/j.issn.1008-1062.2017.02.003.
Li W, Tang RJ, Peng JQ, et al. The analysis of ADC value's standard deviation and ROI for prediction the short-term therapeutic effect in nasopharyngeal carcinoma[J]. J Chin Clin Med Imaging, 2017, 28(2):85-88. doi: 10.3969/j.issn.1008-1062.2017.02.003

[9]

Orecchia R, Surgo A, Muto M, et al. VERO^® radiotherapy for low burden cancer: 789 patients with 957 lesions[J/OL]. Ecancermedicalscience, 2016, 10: 677[2017-11-07]. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27729942. DOI: 10.3332/ecancer.2016.677.

[10]

Degener S, Pohle A, Strelow H, et al. Long-term experience of hyperbaric oxygen therapy for refractory radio-or chemotherapy-induced haemorrhagic cystitis[J/OL]. BMC Urol, 2015, 15: 38[2017-11-07]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423090. DOI: 10.1186/s12894-015-0035-4.

[11]

Nunes LA, Mussavira S, Bindhu OS. Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid:a systematic review[J]. Biochem Med(Zagreb), 2015, 25(2):177-192. DOI:10.11613/BM.2015.018.

[12]

Fallahi B, Beiki D, Abedi SM, et al. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?[J]. Nucl Med Commun, 2013, 34(8):777-786. DOI:10.1097/MNM.0b013e328362b1f2.

[13]

Badam RK, Suram J, Babu DB, et al. Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients[J]. J Clin Diagn Res, 2016, 10(1):ZC60-ZC62. DOI:10.7860/JCDR/2016/16091.7121.

[14]

张行涛, 苏莉, 黄诚刚, 等.分化型甲状腺癌¹³¹I治疗后唾液腺损伤评价及预防[J].口腔医学研究, 2012, 28(5):472-475.
Zhang XT, Su L, Huang CG, et al. The evaluation and prevention of the salivary gland toxicity of the differentiated thyroid carcinoma after ¹³¹I therapy[J]. J Oral Sci Res, 2012, 28(5):472-475.

[15]

Upadhyaya A, Meng Z, Wang P, et al. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer[J/OL]. Medicine(Baltimore), 2017, 96(25): e7164[2017-11-07]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484202. DOI: 10.1097/MD.0000000000007164.

[16]

姚晓波, 金晓毛, 何静, 等. ¹³¹碘治疗甲状腺癌患者后唾液腺功能的变化分析[J].安徽医科大学学报, 2012, 47(1):67-71. DOI:10.3969/j.issn.1000-1492.2012.01.019.
Yao XB, Jin XM, He J, et al. The variation of salivary gland function in patients with thyroid carcinoma after ¹³¹I treatment[J]. Acta Universitatis Medicinalis Anhui, 2012, 47(1):67-71. doi: 10.3969/j.issn.1000-1492.2012.01.019